1
|
W RosamondK FlegalK FurieA GoK GreenlundN
HaaseSM HailpernM HoV HowardB KisselaS KittnerD Lloyd-JonesM
McDermottJ MeigsC MoyG NicholC O’DonnellV RogerP SorlieJ
SteinbergerT ThomM WilsonY HongAmerican Heart Association
Statistics Committee and Stroke Statistics SubcommitteeHeart
disease and stroke statistics-2008 update: a report from the
American Heart Association Statistics Committee and Stroke
Statistics
SubcommitteeCirculation117e25e146200810.1161/CIRCULATIONAHA.107.18799818086926
|
2
|
C CannonE BraunwaldUnstable angina and
non-ST elevation myocardial infarction In: Harrison’s Principles of
Internal MedicineDL KasperE BraunwaldAS FauciSL HauserDL LongoJL
Jameson16th editionMcGraw-HillNew York144414482005
|
3
|
E JawadR AroraChronic stable angina
pectorisDis Mon54671689200810.1016/j.disamonth.2008.06.009
|
4
|
V BittnerBD JohnsonI ZinehWJ RogersD
VidoOC MarroquinCN Bairey-MerzG SopkoThe triglyceride/high-density
lipoprotein cholesterol ratio predicts all-cause mortality in women
with suspected myocardial ischemia: a report from the Women’s
Ischemia Syndrome Evaluation (WISE)Am Heart
J157548555200919249427
|
5
|
K ThygesenJS AlpertHD WhiteJoint
ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial
InfarctionAS JaffeFS AppleM GalvaniHA KatusLK NewbyJ RavkildeB
ChaitmanPM ClemmensenM DellborgH HodP PorelaR UnderwoodJJ BaxGA
BellerR BonowEE Van der WallJP BassandW WijnsTB FergusonPG StegBF
UretskyDO WilliamsPW ArmstrongEM AntmanKA FoxCW HammEM OhmanML
SimoonsPA Poole-WilsonEP GurfinkelJL Lopez-SendonP PaisS MendisJR
ZhuLC WallentinF Fernández-AvilésKM FoxAN ParkhomenkoSG PrioriM
TenderaLM Voipio-PulkkiA VahanianAJ CammR De CaterinaV DeanK
DicksteinG FilippatosC Funck-BrentanoI HellemansSD KristensenK
McGregorU SechtemS SilberM TenderaP WidimskyJL ZamoranoJ MoraisS
BrenerR HarringtonD MorrowM LimMA Martinez-RiosS SteinhublGN
LevineWB GiblerD GoffM TubaroD DudekN Al-AttarUniversal definition
of myocardial
infarctionCirculation11626342653200710.1161/CIRCULATIONAHA.107.18739717951284
|
6
|
G WalldiusI JungnerIs there a better
marker of cardiovascular risk than LDL cholesterol? Apolipoproteins
B and A-I-new risk factors and targets for therapyNutr Metab
Cardiovasc Dis17565571200710.1016/j.numecd.2007.02.01017631989
|
7
|
S TsimikasJT WillersonPM RidkerC-Reactive
protein and other emerging blood biomarkers to optimize risk
stratification of vulnerable patientsJ Am Coll
Cardiol47C19C31200610.1016/j.jacc.2005.10.06616631506
|
8
|
XS HuangSP ZhaoQ ZhangL BaiM HuElevated
plasma apolipoprotein AV in acute coronary syndrome is positively
correlated with triglyceride and C-reactive proteinChin Med J
(Engl)12214081412200919567162
|
9
|
J TashiroO MiyazakiY NakamuraA MiyazakiI
FukamachiH BujoY SaitoPlasma pre beta1-HDL level is elevated in
unstable angina
pectorisAtherosclerosis204595600200910.1016/j.atherosclerosis.2008.10.01519054517
|
10
|
KH ChoDG ShinSH BaekJR KimMyocardial
infarction patients showed altered lipoprotein properties and
functions when compared with stable angina pectoris patientsExp Mol
Med416776200910.3858/emm.2009.41.2.009
|
11
|
SJ LeeH CamposLA MoyeFM SacksLDL
containing apolipoprotein CIII is an independent risk factor for
coronary events in diabetic patientsArterioscler Thromb Vasc
Biol23853858200310.1161/01.ATV.0000066131.01313.EB12637336
|
12
|
M HartfordO WiklundL Mattsson HulténA
PerssonT KarlssonJ HerlitzK CaidahlC-reactive protein,
interleukin-6, secretory phospholipase A group IIA and
intercellular adhesion molecule-1 in the prediction of late outcome
events after acute coronary syndromesJ Intern
Med262526536200710.1111/j.1365-2796.2007.01862.x
|
13
|
KH ParkDG ShinJR KimKH ChoThe functional
and compositional properties of lipoproteins are altered in
patients with metabolic syndrome with increased cholesteryl ester
transfer protein activityInt J Mol Med251291362010
|
14
|
T McLaughlinF AbbasiK ChealJ ChuC
LamendolaG ReavenUse of metabolic markers to identify overweight
individuals who are insulin resistantAnn Intern
Med139802809200310.7326/0003-4819-139-10-200311180-0000714623617
|
15
|
JJ Genest JrSS Martin-MunleyJR McNamaraJM
OrdovasJ JennerRH MyersSR SilbermanPW WilsonDN SalemEJ
SchaeferFamilial lipoprotein disorders in patients with premature
coronary artery
diseaseCirculation8520252033199210.1161/01.CIR.85.6.20251534286
|
16
|
RJ HavelHA EderJH BragdonThe distribution
and chemical composition of ultracentrifugally separated
lipoproteins in human serumJ Clin
Invest3413451353195510.1172/JCI10318213252080
|
17
|
MA MarkwellSM HaasLL BieberNE TolbertA
modification of the Lowry procedure to simplify protein
determination in membrane and lipoprotein samplesAnal
Biochem87206210197810.1016/0003-2697(78)90586-998070
|
18
|
MS BloisAntioxidant determinations by the
use of a stable free
radicalNature18111991200195810.1038/1811199a0
|
19
|
IF BenzieJJ StrainThe ferric reducing
ability of plasma (FRAP) as a measure of antioxidant power: the
FRAP assayAnal Biochem2397076199610.1006/abio.1996.02928660627
|
20
|
KH ChoSynthesis of reconstituted
high-density lipoprotein (rHDL) containing apoA-I and apoC-III: the
functional role of apoC-III in rHDLMol
Cells27291297200910.1007/s10059-009-0037-819326075
|
21
|
JM HanTS JeongWS LeeI ChoiKH ChoStructural
and functional properties of V156K and A158E mutants of
apolipoprotein A-I in the lipid-free and lipid-bound statesJ Lipid
Res46589596200510.1194/jlr.M400468-JLR20015716588
|
22
|
KH ChoJY LeeMS ChoiJM ChoJS LimYB ParkA
peptide from hog plasma that inhibits human cholesteryl ester
transfer proteinBiochim Biophys
Acta1391133144199810.1016/S0005-2760(97)00197-59554982
|
23
|
HW EckersonCM WyteBN La DuThe human serum
paraoxonase/arylesterase polymorphismAm J Hum
Genet351126113819836316781
|
24
|
HF BoydSC FellST FlynnDM HickeyRJ IfeCA
LeachCH MacpheeKJ MillinerKE MooresIL PintoRA PorterDA RawlingsSA
SmithIG StansfieldDG TewCJ TheobaldCM WhittakerN-1 substituted
pyrimidin-4-ones: novel, orally active inhibitors of
lipoprotein-associated phospholipase A2Bioorg Med Chem
Lett1025572561200010.1016/S0960-894X(00)00510-211086729
|
25
|
KH ChoSH ParkJE ParkYO KimI ChoiJJ KimJR
KimThe function, composition, and particle size of high-density
lipoprotein were severely impaired in an oliguric phase of
hemorrhagic fever with renal syndromeClin
Biochem415664200810.1016/j.clinbiochem.2007.10.00717996200
|
26
|
A JahangiriMC de BeerV NoffsingerLR
TannockC RamaiahNR WebbDR van der WesthuyzenFC de BeerHDL
remodeling during the acute phase responseArterioscler Thromb Vasc
Biol29261267200910.1161/ATVBAHA.108.17868119008529
|
27
|
PE McBrideTriglycerides and risk for
coronary heart diseaseJ Am Med
Assoc298336338200710.1001/jama.298.3.33617635897
|
28
|
P LibbyFat fuels the flame
triglyceride-rich lipoproteins and arterial
inflammationCirculation100299301200710.1161/01.RES.0000259393.89870.5817307968
|
29
|
R OstfeldD MookherjeeM SpinelliD HoltzmanA
ShoyebM SchaeferS DoddamaniD SpevackY DuA triglyceride/high-density
lipoprotein ratio > or = 3.5 is associated with an increased
burden of coronary artery disease on cardiac catheterizationJ
Cardiometab Syndr113152006
|
30
|
KH ParkDG ShinJR KimKH
ChoSenescence-related truncation and multimerization of
apolipoprotein A-I in high-density lipoprotein with an elevated
level of advanced glycated end products and cholesteryl ester
transfer activityJ Gerontol A Biol Sci Med
Sci65600610201010.1093/gerona/glq034
|
31
|
MJ ChapmanWL GoffM GuerinA
KontushCholesteryl ester transfer protein: at the heart of the
action of lipid-modulating therapy with statins, fibrates, niacin,
and cholesteryl ester transfer protein inhibitorsEur Heart
J31149164201010.1093/eurheartj/ehp399
|
32
|
MJ ChapmanTherapeutic elevation of
HDL-cholesterol to prevent atherosclerosis and coronary heart
diseasePharmacol
Ther111893908200610.1016/j.pharmthera.2006.02.00316574234
|
33
|
M ZellerD MassonM FarnierL LorgisV
DeckertJP Pais de BarrosC DesrumauxP SicardJ GroberD BlacheP
GambertL RochetteY CottinL LagrostHigh serum cholesteryl ester
transfer rates and small high-density lipoproteins are associated
with young age in patients with acute myocardial infarctionJ Am
Coll Cardiol5019481955200710.1016/j.jacc.2007.06.05217996559
|
34
|
BJ ArsenaultI LemieuxJP DesprésP GagnonNJ
WarehamES StroesJJ KasteleinKT KhawSM BoekholdtHDL particle size
and the risk of coronary heart disease in apparently healthy men
and women: the EPIC-Norfolk prospective population
studyAtherosclerosis206276281200910.1016/j.atherosclerosis.2009.01.044
|
35
|
M GurM AslanA YildizR DemirbagR YilmazS
SelekO ErelI OzdogruParaoxonase and arylesterase activities in
coronary artery diseaseEur J Clin
Invest36779787200610.1111/j.1365-2362.2006.01727.x17032345
|
36
|
K KarasawaClinical aspects of plasma
platelet-activating factor-acetylhydrolaseBiochim Biophys
Acta176113591372200610.1016/j.bbalip.2006.06.01717049457
|
37
|
DA SixEA DennisThe expanding superfamily
of phospholipase A(2) enzymes: classification and
characterizationBiochim Biophys
Acta1488119200010.1016/S1388-1981(00)00105-011080672
|